Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05713929
Other study ID # B4062022000256
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 6, 2023
Est. completion date August 31, 2023

Study information

Verified date March 2023
Source Erasme University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this interventional study is to learn about the effects of different positions on the occurrence, regional distribution and reversibility of atelectasis by using a PulmoVista 500 monitor (Dräger. 23542 Lübeck), during general anesthesia with mechanical ventilation. The main questions it aims to answer are: - The increase in atelectasis after induction of general anesthesia in supine and Trendelenburg position compared with baseline (spontaneous breathing) - The eventual possibility of reversal of atelectasis caused by general anesthesia and Trendelenburg position by reverse Trendelenburg position and recruitment manÅ“uvre. Participants will be adult, autonomous and able to express their will, undergoing elective gynecological or urological surgery in the extended Trendelenburg position.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date August 31, 2023
Est. primary completion date August 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Adult subjects over eighteen years old; - Requiring laparoscopic gynecological, urological or digestive surgery; - Surgery requiring Trendelenburg position and tracheal intubation. Exclusion Criteria: - Emergency operation; - Thoracic surgery; - Pulmonary, cardiac pathology; - Pregnant woman; - BMI > 30; - Comorbidities defined as an American Society of Anesthesiologists physical condition greater than 2; - Language barrier; - Refusal of consent.

Study Design


Intervention

Other:
Recruitment maneuver (RM)
performance of a recruitment maneuver of 30 cm H20 for 30 seconds and measurement of electrical impedance
Reverse Trend (REV TREND)
Place the patient in the reverse trendelenburg position and measuring the electrical impedance after 5 minutes

Locations

Country Name City State
Belgium HUB Hôpital Erasme Brussels Anderlecht

Sponsors (1)

Lead Sponsor Collaborator
Erasme University Hospital

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary the percentage of atelectasis after induction of general anesthesia (Time 1) percentage from the base measure to time 1 (10 minutes)
Primary the percentage of atelectasis after being positioned in the trendelenburg position (Time 2) percentage from the base measure to time 2 (15 minutes)
Secondary The eventual possibility of reversal of atelectasis by reverse Trendelenburg position and recruitment maneuver (Time 3) percentage from the base measure to time 3 (20 minutes)
See also
  Status Clinical Trial Phase
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Completed NCT03038945 - Barbed vs Standard Suture for Laparoscopic Vaginal Cuff Closure N/A
Recruiting NCT02671253 - Myomectomies:Tumor Characteristics and Clinical Implications N/A
Recruiting NCT06137976 - Surgeon Perception of Gastric Decompression at Time of Gynecologic Laparoscopy N/A
Completed NCT04142203 - Implementation of 23 Hour Surgery Model in a Tertiary Hospital
Completed NCT03256396 - Intraoperative PEEP Setting During Laparoscopic Gynecologic Surgery N/A
Recruiting NCT04154683 - Optical Biopsy in Gynecological Surgery N/A
Withdrawn NCT04505111 - Prehabilitation Plus ERAS vs ERAS in Gynecological Surgery N/A
Completed NCT00186732 - Comparison of Subcuticular Suture Versus Surgical Staples for Closure of Pfannenstiel Skin Incisions N/A
Completed NCT02896036 - Veress Entry With/Without Concomitant CO2 N/A
Enrolling by invitation NCT05773950 - Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant as PONV Prevention N/A
Completed NCT01940419 - Testing of the Drug Tranexamic Acids as Prophylaxis of Bleeding in Benign Surgical Removal of the Uterus Phase 4